Michael S Hearne Insider Trading
Get free email notifications about insider trading for Michael S Hearne.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael S Hearne. Michael S Hearne is a Chief Financial Officer in LA JOLLA PHARMACEUTICAL CO ($LJPC) and a Chief Financial Officer in Odonate Therapeutics, Inc. ($ODT).
Address: C/O ODONATE THERAPEUTICS, INC. 4747 EXECUTIVE DRIVE, SUITE 510 SAN DIEGO 92121 CA
Companies in which Michael S Hearne is an Insider
LA JOLLA PHARMACEUTICAL CO
Trading Symbol: LJPCIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Michael S Hearne: Chief Financial Officer
Holdings: 3,934 shares
Current Value: $76,595
Latest Transaction: Jun 02 2021
$LJPC Market Capitalization: $355.22M
$LJPC Previous Close: $19.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Odonate Therapeutics, Inc.
Trading Symbol: ODTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael S Hearne: Chief Financial Officer
Holdings: 2,583 shares
Latest Transaction: Mar 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Michael S Hearne
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.30 | 169 | 727 | 169 | |
Jun 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.66 | 169 | 618 | 3,934 | 3.8 K to 3.9 K (+4.49 %) |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.44 | 163 | 724 | 163 | |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.77 | 163 | 615 | 3,572 | 3.4 K to 3.6 K (+4.78 %) |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.18 | 173 | 723 | 173 | |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.55 | 173 | 615 | 3,835 | 3.7 K to 3.8 K (+4.72 %) |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.18 | 173 | 723 | 173 |